[Cardiovascular disorders in the course of antimitotic infusions at high doses. 30 clinical cases].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D010478:Chemotherapy, Cancer, Regional Perfusion; D004562:Electrocardiography; D004617:Embolism / Q000139:chemically induced*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D012772:Shock, Septic; D013610:Tachycardia / Q000139:chemically induced*; D014747:Vinblastine / Q000009:adverse effects
D000970:Antineoplastic Agents; D014747:Vinblastine; D005472:Fluorouracil; D008727:Methotrexate
Trobules cardio-vasculaires au cours d'infections d'anti-mitotiques à fortes doses. 30 observations cliniques.